Found 21 matching trials
FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH) PHASE3 This study was an international, multi-center, randomized, double-blind, pl...
Show More Location
University of Alabama-Birmingham
Learn More & Join Trial
FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) PHASE3 This study is an international, multi-center, randomized, double-blind, pla...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers PHASE1 A study to assess the interaction of acohol and oral treprostinil....
Location
PPD International
Learn More & Join Trial
TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH) PHASE4 This was an open-label extension of Study RIV-PH-402, TRUST-1: Treprostinil...
Show More Location
Multiple Locations
Learn More & Join Trial
A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil). PHASE4 The Study Hypothesis:
Aggressive, upfront, dual therapy for treatment-naïv...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension PHASE3 This study provided/continued to provide oral treprostinil (UT-15C SR; trep...
Show More Location
The Kirklin Clinic
Learn More & Join Trial
Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine PHASE1 This study will compare the bioavailability and pharmacokinetics of the 0.5...
Show More Learn More & Join Trial
Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis PHASE2 The purpose of this study is to establish single-dose tolerability of inhal...
Show More Location
UCSD Medical Center m/c7381
Learn More & Join Trial
Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH PHASE2 This is a multicenter, single-arm trial to evaluate the safety of the trans...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension N/A This was a multicenter, prospective, observational, open-label study. Patie...
Show More Location
University of California, Los Angeles
Learn More & Join Trial